
A randomized study found that zoledronic acid significantly increased spine bone mass and prevented hip bone loss in bariatric surgery patients. After 12 months, spine vBMD increased by 2.6% in the treatment group, while hip bone loss was reduced compared to placebo. These findings suggest that zoledronic acid may be effective in preserving bone health post-bariatric surgery.
Like
Save
Share